Will you be at J.P. Morgan in San Francisco this year? Schedule a meeting with our CEO, Paula Brown Stafford, to learn how Allucent’s tech-enabled, specialty approach helps mid-size biopharma companies accelerate their drug development programs.
Explore our full range of services – from Clinical Operations and Biostatistics to Clinical Pharmacology/Modeling and Simulation, and Regulatory and Drug Development Consulting – designed to create exceptional customer experiences that foster loyalty and partnership. Through operational excellence, personalized support, and proactive service, we deliver meaningful value by understanding and anticipating your needs.
Paula Brown Stafford, Chief Executive Officer
Paula Brown Stafford is CEO of Allucent, with over 35 years of industry experience. At Quintiles (now IQVIA), she helped expand CRO services, leading 22,000 team members across 60 countries in delivering Phase I-IV clinical research. Later, as President and CEO of Novan, Inc., Ms Stafford gained deep insight into the needs of small and mid-sized biotech and pharma companies, a perspective she brings to Allucent.
Fill out the form to schedule a meeting.
Share This
